138 related articles for article (PubMed ID: 12661573)
1. Management of latent tuberculosis infection in immigrants.
Sterling T; Munsiff SS; Frieden TR
N Engl J Med; 2003 Mar; 348(13):1289-92; author reply 1289-92. PubMed ID: 12661573
[No Abstract] [Full Text] [Related]
2. Management of latent tuberculosis infection in immigrants.
Menzies D; Schwartzman K
N Engl J Med; 2003 Mar; 348(13):1289-92; author reply 1289-92. PubMed ID: 12661572
[No Abstract] [Full Text] [Related]
3. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States.
Khan K; Muennig P; Behta M; Zivin JG
N Engl J Med; 2002 Dec; 347(23):1850-9. PubMed ID: 12466510
[TBL] [Abstract][Full Text] [Related]
4. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
Jasmer RM; Snyder DC; Saukkonen JJ; Hopewell PC; Bernardo J; King MD; Kawamura LM; Daley CL;
Clin Infect Dis; 2004 Feb; 38(3):363-9. PubMed ID: 14727206
[TBL] [Abstract][Full Text] [Related]
5. Management of latent tuberculosis infection in immigrants.
Marks SM; Ijaz K; Iademarco MF
N Engl J Med; 2003 Mar; 348(13):1289-92; author reply 1289-92. PubMed ID: 12660398
[No Abstract] [Full Text] [Related]
6. Treatment of latent tuberculosis infection: back to the beginning.
Blumberg HM
Clin Infect Dis; 2004 Dec; 39(12):1772-5. PubMed ID: 15578398
[No Abstract] [Full Text] [Related]
7. Clinical practice. Latent tuberculosis infection.
Jasmer RM; Nahid P; Hopewell PC
N Engl J Med; 2002 Dec; 347(23):1860-6. PubMed ID: 12466511
[No Abstract] [Full Text] [Related]
8. [Primary tuberculosis of the tongue].
Benmansour N; El hord S; Oudidi A; Benjelloun MC; El alami MN
J Otolaryngol Head Neck Surg; 2009 Apr; 38(2):E73-5. PubMed ID: 19442360
[No Abstract] [Full Text] [Related]
9. Latent tuberculosis infection in children: a call for revised treatment guidelines.
Finnell SM; Christenson JC; Downs SM
Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
[TBL] [Abstract][Full Text] [Related]
10. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
Stout JE
Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
[TBL] [Abstract][Full Text] [Related]
11. Latent tuberculous infection.
Yun JS; Lazarus AA; Gilbert R
Dis Mon; 2006; 52(11-12):441-5. PubMed ID: 17157617
[No Abstract] [Full Text] [Related]
12. Tuberculosis: guidelines changed for latent TB treatment.
AIDS Treat News; 2001 Sep; (371):3. PubMed ID: 11668976
[No Abstract] [Full Text] [Related]
13. Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing program.
Priest DH; Vossel LF; Sherfy EA; Hoy DP; Haley CA
Clin Infect Dis; 2004 Dec; 39(12):1764-71. PubMed ID: 15578397
[TBL] [Abstract][Full Text] [Related]
14. Whither the roles of rifater and rifamate?
McConville JH
Pa Med; 1996 Mar; 99(3):24-5. PubMed ID: 8692580
[No Abstract] [Full Text] [Related]
15. Rifampin and pyrazinamide for treatment of latent tuberculosis infection.
Cook PP
Clin Infect Dis; 2006 Mar; 42(6):892; author reply 892-3. PubMed ID: 16477576
[No Abstract] [Full Text] [Related]
16. Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners.
Chaisson RE; Armstrong J; Stafford J; Golub J; Bur S
JAMA; 2002 Jul; 288(2):165-6. PubMed ID: 12095379
[No Abstract] [Full Text] [Related]
17. Revised treatment and testing guidelines for latent tuberculosis infection.
Rep Med Guidel Outcomes Res; 2000 Apr; 11(9):9-10. PubMed ID: 11770514
[No Abstract] [Full Text] [Related]
18. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker TG; Lötter AP
Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
[No Abstract] [Full Text] [Related]
19. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
20. Rifampin and pyrazinamide for latent tuberculosis infection: clinical trials and general practice.
Saukkonen J
Clin Infect Dis; 2004 Aug; 39(4):566-8. PubMed ID: 15356823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
